Reduction in the urinary aflatoxin M₁ biomarker as an early indicator of the efficacy of dietary interventions to reduce exposure to aflatoxins

Abstract

Aflatoxin B₁ is a persistent public health issue in Ghana. Assessment of AFB₁ intervention efficacy is currently dependent on long-term biomarkers. This study was designed to determine whether daily AFM₁ biomarker levels could be utilized as an early detection method for intervention efficacy. Participants were treated with a refined calcium montmorillonite clay (UPSN) or a placebo (calcium carbonate) in a crossover study. Urine samples were assessed for AFM₁ levels daily. UPSN treatment reduced AFM₁ biomarkers by 55% compared to the placebo. This is the first study to show that daily urinary AFM₁ levels can be used as a biomarker of internal aflatoxin B₁ exposure in short-term intervention trials to determine efficacy.

• Aflatoxin
• enterosorption therapy
• Ghana
• liver cancer

Acknowledgements

The authors would like to gratefully acknowledge the on-site physicians, technicians and other health personnel at the Ejura District Health Services.